ArticleHeliyon2024
Case report: Metastatic gastric squamous cell carcinoma with long duration of complete response via three-staged radical concurrent chemoradiotherapy.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Primary Gastric Squamous Cell Carcinoma (GSCC), especially in late-stage, is a very rare pathological type with poor prognosis. We report a long duration of Complete Response (CR) of GSCC case with multiple metastases by an elaborate three-staged radical Concurrent Chemoradiotherapy (CCRT). Case presentation: A 36-year-old male suffered from weakness and melena, and then was diagnosed as primary GSCC with cT3N3M1, Stage IV. According to the characteristics of multiple lymph nodes metastases at supraclavicular, perigastric and pelvic regions, an individualized therapeutic strategy of three-staged radical CCRT was elaborately designed and cautiously performed even after the accidental massive hemorrhage of the upper digestive tract under the guidance of a multidisciplinary team. A long-term CR was achieved, with Progression Free Survival (PFS) and Overall Survival (OS) of 74 months by the last follow-up. The case with multiple metastases was radically treated as local advanced disease with complete success. Conclusion: Patient with stage IV mGSCC who has achieved CR and unexpected long-term PFS and OS through CCRT due to precise judgement and well-designed individualized therapy. The immunomodulatory effect of radiation therapy on the tumor microenvironment may be a potential mechanism affecting treatment efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.